University of Arizona

The development of personalized medicine to treat diseases depends heavily upon a highly detailed level of understanding of biological processes that are inherently difficult to measure. Now, nanomaterial technology developed at the University of Arizona and licensed to startup Scintillation Nanotechnologies is making it possible for scientists to take a closer look at the processes that drive diseases in order to improve patient outcomes.